Medical Disposables Market size is set to gain remarkable traction from 2022 to 2028, due to the steady shift from the use of reusable medical devices to disposable medical supplies to lower the risk of cross-contamination and surgical-site infections. Likewise, the rising adoption of bioplastics across the healthcare sector to curb environmental footprint will further boost the production of biodegradable medical disposables and supplies in the coming years. Medical disposables refer to systems intended to be used once or temporarily to render quality patient care. These single-use products include gloves, face masks, blood bags, and needles, which can replace conventional equipment that involves a costly and time-consuming sterilization procedure.
High incidence of chronic conditions and the subsequent increase in the rate of hospitalizations are some of the factors bolstering overall medical disposables market trends through 2028. As per the 2021 CDC Report, six in ten Americans live with at least one chronic disease, such as cancer, stroke, and diabetes, which will push the demand for disposable medical disposable products across the healthcare setting. Furthermore, the increasing prevalence of hospital-acquired infections is also likely to add impetus to the industry dynamics. However, concerns regarding environmental pollution associated with the usage of disposable masks may create a negative impact on market share during the forecast timeframe.
Based on product type, the surgical instruments and supplies segment is projected to hold a considerable share in the market by 2028. This is given the rapid technological advancements and the growing acceptance of minimally invasive treatment worldwide, amplifying the deployment of disposable surgical gloves and other products. The segment growth will further be driven by the increasing reliance on ambulatory surgical centers (ASC) to perform outpatient surgery. According to Fierce Healthcare’s data, procedures at ASCs are anticipated to surge by 6%-7% per year through 2021, which will influence the overall market forecast.
Asia Pacific medical disposables market will amass hefty profits by 2028, on account of the increased health spending despite the lower fiscal revenue during the COVID-19 pandemic in emerging economies such as China. Based on a report by the State Council of the People’s Republic of China, public health expenditure rose by 15.2 percent to nearly $293 billion in 2021 as compared to a year earlier. This, along with the rise in the elderly population and the high burden of chronic diseases, will also serve as major factors propelling the regional size over the coming years.
Prominent players in the market include Gerresheimer AG, 3M Company, Terumo Medical Corporation, STERIS plc, Smiths Medical, Smith & Nephew, Medline Industries, Inc., Kimberly-Clark Corporation, Johnson & Johnson, Covidien plc (Ethicon), ConvaTec Inc., Cardinal Health, B. Braun, Boston Scientific, Baxter International, BD, Ansell Limited, Ahlstrom-Munksjo, and Abbott Laboratories, among others. These firms are focusing on business expansions and other strategies to reinforce their presence in the global market. For instance, in August 2021, Boston Scientific gained the U.S. FDA 510(k) clearance for its single-use, disposable bronchoscope, designed to eliminate the risk of infection associated with reusable devices.
The ongoing coronavirus pandemic has posed a profound impact on the healthcare sector worldwide, particularly in terms of medical device assembly and manufacturing. The emergence of remote working and supply chain disruptions also have influenced the way businesses are conducted. These challenges may have created an impact on the industry over the past months. Also, the escalating rate of hospitalization of COVID-19-infected patients and the surging cases of HAIs such as VAE infection may aid industry recovery over the coming years.
Market, by Product Type
Market, by Raw Material
Market, by End-use
The above information is provided for the following regions and countries: